Characterization of CD22 Expression in Acute Lymphoblastic Leukemia

BACKGROUND: CD22 is a B-lineage differentiation antigen that has emerged as a leading therapeutic target in acute lymphoblastic leukemia (ALL). PROCEDURE: Properties of CD22 expression relevant to therapeutic targeting were characterized in primary samples obtained from children and young adults wit...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Pediatr Blood Cancer
Главные авторы: Shah, Nirali N., Stetler-Stevenson, Maryalice, Yuan, Constance M., Richards, Kelly, Delbrook, Cindy, Kreitman, Robert J., Pastan, Ira, Wayne, Alan S.
Формат: Artigo
Язык:Inglês
Опубликовано: 2015
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4405453/
https://ncbi.nlm.nih.gov/pubmed/25728039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25410
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы